Federico Micheli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Federico Micheli has a total of 207 co-authors. Here are the top co-authors by number of shared publications:
Gabriela Raina
Parkinson’s Disease and Movement Disorders Program, Hospital de Clínicas “José de San Martín”, University of Buenos Aires, Buenos Aires, Argentina
5 shared publicationsVictoria Aldinio
Parkinson's Disease and Movement Disorders Unit, Department of Neurology, Hospital de Clínicas "José de San Martín", Buenos Aires, Argentina
3 shared publicationsCristian Calandra
From Hospital de Clinicas "José de San Martin" (G.B.R., M.G.C., S.S.F., J.C.G., C.C., J.P.P., V.A.T., A.L.T., D.S.C., L.A.P., F.E.M.), Hospital Britanico (M.C.U.R., M.M.F.), and Hospital Español (R.J.G.), CABA, Buenos Aires, Argentina; Movement Disorders and Neurodegenerative Diseases Unit (C.Z.R.), Hospital Civil de Guadalajara "Fray Antonio Alcalde," Guadalajara, Mexico; and Instituto de Ciencias Neurologicas "Luis Trelles Montes" (M.V.), Lima, Peru
2 shared publicationsDaniela S. Calvo
From Hospital de Clinicas "José de San Martin" (G.B.R., M.G.C., S.S.F., J.C.G., C.C., J.P.P., V.A.T., A.L.T., D.S.C., L.A.P., F.E.M.), Hospital Britanico (M.C.U.R., M.M.F.), and Hospital Español (R.J.G.), CABA, Buenos Aires, Argentina; Movement Disorders and Neurodegenerative Diseases Unit (C.Z.R.), Hospital Civil de Guadalajara "Fray Antonio Alcalde," Guadalajara, Mexico; and Instituto de Ciencias Neurologicas "Luis Trelles Montes" (M.V.), Lima, Peru
2 shared publicationsEmilia Gatto
Programa de Parkinson y Movimientos Anormales. Instituto de Neurociencias, Hospital de Clínicas “José de San Martín,” Buenos Aires, Argentina
2 shared publicationsEugenia Conti
Parkinson's Disease and Movement Disorders Unit, Department of Neurology, Hospital de Clínicas "José de San Martín", Buenos Aires, Argentina
2 shared publications
Latest Publications
- Open Access
- 26 February 2025
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 134, 107344
Sex differences in the diagnosis latency of Parkinson's disease in Latin America
- 26 February 2025
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 134, 107344
Open AccessSex differences in the diagnosis latency of Parkinson's disease in Latin America
- 1 September 2020
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 78, 66-67
Cannabis in patients with Parkinson's disease in Argentina. A cross sectional study
- 1 September 2020
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 78, 66-67
Cannabis in patients with Parkinson's disease in Argentina. A cross sectional study
- 3 March 2017
- Published by Wiley in Movement Disorders
- Vol. 32 (3) , 481
Neuropsychiatric symptoms and premanifest Huntington's disease
- 3 March 2017
- Published by Wiley in Movement Disorders
- Vol. 32 (3) , 481
Neuropsychiatric symptoms and premanifest Huntington's disease
- Open Access
- 2 March 2017
- Published by MedCrave Group Kft. in Journal of Neurology & Stroke
- Vol. 6 (3) , 1-3
Continous Idiopathic Facial Myokymia Succesfully Treated with Botulinum Toxin
Introduction: Botulinum toxin infiltration has been suggested useful for focalized myokymia. Methods: 71-year old woman presented continuous undulating movements in her right cheek. EMG was consistent with myokymia. Results: Five units of Onabotulinumtoxin A abolished myokymia. Conclusion: Low doses of Onabotulinumtoxin A are useful in continuous idiopathic facial myokymia.
- 2 March 2017
- Published by MedCrave Group Kft. in Journal of Neurology & Stroke
- Vol. 6 (3) , 1-3
Open AccessContinous Idiopathic Facial Myokymia Succesfully Treated with Botulinum Toxin
Introduction: Botulinum toxin infiltration has been suggested useful for focalized myokymia. Methods: 71-year old woman presented continuous undulating movements in her right cheek. EMG was consistent with myokymia. Results: Five units of Onabotulinumtoxin A abolished myokymia. Conclusion: Low doses of Onabotulinumtoxin A are useful in continuous idiopathic facial myokymia.
- 1 November 2016
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 370, 256-257
Lingual protrusion dystonia: Manifestation during “on” periods in Parkinson's disease
- 1 November 2016
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 370, 256-257
Lingual protrusion dystonia: Manifestation during “on” periods in Parkinson's disease
- 30 July 2016
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 31, 151-152
Task specific dystonia in a juggler
- 30 July 2016
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 31, 151-152
Task specific dystonia in a juggler
- 1 April 2016
- Published by Elsevier in Basal Ganglia
- Vol. 6 (2) , 95-96
Abdominal cramping as a symptom of benign fasciculation syndrome with an excellent response to botulinum toxin
- 1 April 2016
- Published by Elsevier in Basal Ganglia
- Vol. 6 (2) , 95-96
Abdominal cramping as a symptom of benign fasciculation syndrome with an excellent response to botulinum toxin
- 8 March 2016
- Published by Wolters Kluwer Health in Neurology
- Vol. 86 (10) , 931-938
Holmes tremor
Objective: To describe the clinical features, etiology, findings from neuroimaging, and treatment results in a series of 29 patients with Holmes tremor (HT). Methods: A retrospective study was performed based on review of medical records and videos of patients with HT diagnosis. Results: A total of 16 women and 13 men were included. The mean age at the moment of CNS insult was 33.9 ± 20.1 years (range 8–76 years). The most common causes were vascular (48.3%), ischemic, or hemorrhagic. Traumatic brain injury only represented 17.24%; other causes represented 34.5%. The median latency from lesion to tremor onset was 2 months (range 7 days–228 months). The most common symptoms/signs associated with HT were hemiparesis (62%), ataxia (51.7%), hypoesthesia (27.58%), dystonia (24.1%), cranial nerve involvement (24.1%), and dysarthria (24.1%). Other symptoms/signs were vertical gaze disorders (6.8%), bradykinesia/rigidity (6.8%), myoclonus (3.4%), and seizures (3.4%). Most of the patients had lesions involving more than one area. MRI showed lesions in thalamus or midbrain or cerebellum in 82.7% of the patients. Levodopa treatment was effective in 13 out of 24 treated patients (54.16%) and in 3 patients unilateral thalamotomy provided excellent results. Conclusions: The most common causes of HT in our series were vascular lesions. The most common lesion topography was mesencephalic, thalamic, or both. Treatment with levodopa and thalamic stereotactic lesional surgery seems to be effective.
- 8 March 2016
- Published by Wolters Kluwer Health in Neurology
- Vol. 86 (10) , 931-938
Holmes tremor
Objective: To describe the clinical features, etiology, findings from neuroimaging, and treatment results in a series of 29 patients with Holmes tremor (HT). Methods: A retrospective study was performed based on review of medical records and videos of patients with HT diagnosis. Results: A total of 16 women and 13 men were included. The mean age at the moment of CNS insult was 33.9 ± 20.1 years (range 8–76 years). The most common causes were vascular (48.3%), ischemic, or hemorrhagic. Traumatic brain injury only represented 17.24%; other causes represented 34.5%. The median latency from lesion to tremor onset was 2 months (range 7 days–228 months). The most common symptoms/signs associated with HT were hemiparesis (62%), ataxia (51.7%), hypoesthesia (27.58%), dystonia (24.1%), cranial nerve involvement (24.1%), and dysarthria (24.1%). Other symptoms/signs were vertical gaze disorders (6.8%), bradykinesia/rigidity (6.8%), myoclonus (3.4%), and seizures (3.4%). Most of the patients had lesions involving more than one area. MRI showed lesions in thalamus or midbrain or cerebellum in 82.7% of the patients. Levodopa treatment was effective in 13 out of 24 treated patients (54.16%) and in 3 patients unilateral thalamotomy provided excellent results. Conclusions: The most common causes of HT in our series were vascular lesions. The most common lesion topography was mesencephalic, thalamic, or both. Treatment with levodopa and thalamic stereotactic lesional surgery seems to be effective.
- 26 February 2016
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 364, 50-52
Gerstmann-Sträussler-Scheinker syndrome in an Argentinean family due to mutationat codon 117 of the Prion Protein Gene (PrPA117V)
- 26 February 2016
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 364, 50-52
Gerstmann-Sträussler-Scheinker syndrome in an Argentinean family due to mutationat codon 117 of the Prion Protein Gene (PrPA117V)
- Open Access
- 6 November 2015
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 123 (3) , 259
Erratum to: Strategies for treatment of dystonia
- 6 November 2015
- Published by Springer Nature in Journal of Neural Transmission
- Vol. 123 (3) , 259
Open AccessErratum to: Strategies for treatment of dystonia